Stock Price
287.50
Daily Change
1.50 0.52%
Monthly
11.48%
Yearly
-36.97%
Q2 Forecast
285.05

Novo Nordisk reported DKK13.6B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Bausch Health Companies USD 979M 55M Mar/2026
Bristol-Myers Squibb USD 3.86B 1.07B Mar/2026
Eli Lilly USD 3.58B 205M Mar/2026
GlaxoSmithKline GBP 1.88B 736M Mar/2026
Merck USD 2.94B 380M Mar/2026
Novartis USD 3.46B 83M Mar/2026
Novo Nordisk DKK 13.6B 1.55B Mar/2026
Novo Nordisk DKK 1.95B 10.94B Jun/2025
Pacira USD 50.74M 3.89M Mar/2026
Sanofi EUR 3.67B 621M Mar/2026
Supernus Pharmaceuticals USD 49.04M 1.5M Mar/2026